Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Clinical trial NCT01756339 · COMPLETED
Trial details
- NCT number
- NCT01756339
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 860
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.